Decreased expression of type 1 fimbriae by a pst mutant of uropathogenic Escherichia coli reduces urinary tract infection

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2802-2815

  Crépin, Sébastien ^a,b   Houle, Sébastien ^a   Charbonneau, Marie ésve ^b   Mourez, Michaël ^b   Harel, Josée ^b   Dozois, Charles M ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN; FIMBRIA PROTEIN TYPE 1; RECOMBINASE; RECOMBINASE FIMS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BLADDER EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; FIMA BACTERIAL GENE; FIMB BACTERIAL GENE; FIMBRIA; FIME BACTERIAL GENE; GENE DELETION; GENE INACTIVATION; IPBA BACTERIAL GENE; IPUA BACTERIAL GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PST BACTERIAL GENE; URINARY TRACT; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; BACTERIAL ADHESION; CELL LINE; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GUANOSINE TETRAPHOSPHATE; HUMANS; MICE; MICE, INBRED CBA; MUTATION; URINARY BLADDER; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84864818030     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00162-12     Document Type: Article

References (87)

1. Aberg A, Shingler V, Balsalobre C. 2006. (p)ppGpp regulates type 1 fimbriation of Escherichia coli by modulating the expression of the sitespecific recombinase FimB. Mol. Microbiol. 60:1520-1533.
2. Aberg A, Shingler V, Balsalobre C. 2008. Regulation of the fimB promoter: a case of differential regulation by ppGpp and DksA in vivo. Mol. Microbiol. 67:1223-1241.
3. Abraham JM, Freitag CS, Clements JR, Eisenstein BI. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 82:5724-5727.
4. Alteri CJ, Lindner JR, Reiss DJ, Smith SN, Mobley HL. 2011. The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol. Microbiol. 82:145-163.
5. Bahrani-Mougeot FK, et al. 2002. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45:1079-1093.
6. Beier D, Gross R. 2006. Regulation of bacterial virulence by twocomponent systems. Curr. Opin. Microbiol. 9:143-152.
7. Bertrand N, et al. 2010. Increased Pho regulon activation correlates with decreased virulence of an avian pathogenic Escherichia coli O78 strain. Infect. Immun. 78:5324-5331.
8. Blattner FR, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1462.
9. Bougdour A, Wickner S, Gottesman S. 2006. Modulating RssB activity: IraP, a novel regulator of sigma(S) stability in Escherichia coli. Genes Dev. 20:884-897.
10. Bryan A, et al. 2006. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 74:1072-1083.
11. Buckles EL, Wang X, Lockatell CV, Johnson DE, Donnenberg MS. 2006. PhoU enhances the ability of extraintestinal pathogenic Escherichia coli strain CFT073 to colonize the murine urinary tract. Microbiology 152:153-160.
12. Calva E, Oropeza R. 2006. Two-component signal transduction systems, environmental signals, and virulence. Microb. Ecol. 51:166-176.
13. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. 2008. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 6:17-27.
14. Cegelski L, et al. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 5:913-919.
15. Cheng C, et al. 2009. Contribution of the pst-phoU operon to cell adher-ence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium. Infect. Immun. 77:1936-1944.
16. Cherepanov PP, Wackernagel W. 1995. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158:9-14.
17. Choi KH, et al. 2005. A Tn7-based broad-range bacterial cloning and expression system. Nat. Methods 2:443-448.
18. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
19. Crepin S, et al. 2011. The Pho regulon and the pathogenesis of Escherichia coli. Vet. Microbiol. 153:82-88.
20. Crepin S, et al. 2008. Genome-wide transcriptional response of an avian pathogenic Escherichia coli (APEC) pst mutant. BMC Genomics 9:568. doi:10.1186/1471-2164-9-568.
21. Dalebroux ZD, Svensson SL, Gaynor EC, Swanson MS. 2010. ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev. 74:171-199.
22. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
23. Dozois CM, et al. 2000. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region. Infect. Immun. 68:4145-4154.
24. Ferreira GM, Spira B. 2008. The pst operon of enteropathogenic Escherichia coli enhances bacterial adherence to epithelial cells. Microbiology 154:2025-2036.
25. Finlay BB, Cossart P. 1997. Exploitation of mammalian host cell functions by bacterial pathogens. Science 276:718-725.
26. Gally DL, Leathart J, Blomfield IC. 1996. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12. Mol. Microbiol. 21:725-738.
27. Garrity-Ryan LK, et al. 2010. Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model. Infect. Immun. 78:4683-4690.
28. Griebling TL. 2007. Urinary tract infection in women, p 587-620. In Litwin MS, Saigal CS (ed), Urologic diseases in America. NIH publication no. 07-5512. U.S. GPO, Washington, DC.
29. Gulig PA, Curtiss R III. 1987. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 55:2891-2901.
30. Gunther NW, IV, et al. 2002. Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or off. Infect. Immun. 70:3344-3354.
31. Hadjifrangiskou M, et al. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol. Microbiol. 80:1516-1529.
32. Hagberg L, et al. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
33. Hannan TJ, et al. 2008. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol. Microbiol. 67:116-128.
34. Hannan TJ, et al. 2012. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 36:616-648.
35. Harel J, Jacques M, Fairbrother JM, Bosse M, Forget C. 1995. Cloning of determinants encoding F165(2) fimbriae from porcine septicaemic Escherichia coli confirms their identity as F1C fimbriae. Microbiology 141: 221-228.
36. Hsieh YJ, Wanner BL. 2010. Global regulation by the seven-component Pi signaling system. Curr. Opin. Microbiol. 13:198-203.
37. Hung DL, Raivio TL, Jones CH, Silhavy TJ, Hultgren SJ. 2001. Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili. EMBO J. 20:1508-1518.
38. Hunstad DA, Justice SS. 2010. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol. 64:203-221.
39. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
40. Klemm P. 1986. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.
41. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseCmediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol. Microbiol. 73:1020-1031.
42. Lamarche MG, et al. 2005. Inactivation of the pst system reduces the virulence of an avian pathogenic Escherichia coli O78 strain. Infect. Immun. 73:4138-4145.
43. Lamarche MG, Harel J. 2010. Membrane homeostasis requires intact pst in extraintestinal pathogenic Escherichia coli. Curr. Microbiol. 60:356-359.
44. Lamarche MG, et al. 2008. Modulation of hexa-acyl pyrophosphate lipid A population under Escherichia coli phosphate (Pho) regulon activation. J. Bacteriol. 190:5256-5264.
45. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
46. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.EMBO J. 19:2803-2812.
47. Miller JF, Mekalanos JJ, Falkow S. 1989. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science 243: 916-922.
48. Miller VL, Mekalanos JJ. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
49. Mobley HL, et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
50. Muller CM, et al. 2009. Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRPcAMP. PLoS Pathog. 5:e1000303. doi:10.1371/journal.ppat.1000303.
51. Mulvey MA, et al. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497.
52. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-4579.
53. Nielubowicz GR, Mobley HL. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7:430-441.
54. Nowicki B, Rhen M, Vaisanen-Rhen V, Pere A, Korhonen TK. 1984. Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J. Bacteriol. 160:691-695.
55. Orndorff PE, Falkow S. 1984. Organization and expression of genes responsible for type 1 piliation in Escherichia coli. J. Bacteriol. 159:736-744.
56. Palaniyandi S, et al. 2012. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073. PLoS One 7:e31348.
57. Posfai G, Koob MD, Kirkpatrick HA, Blattner FR. 1997. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J. Bacteriol. 179:4426-4428.
58. Provence DL, Curtiss R III. 1992. Role of crl in avian pathogenic Escherichia coli: a knockout mutation of crl does not affect hemagglutination activity, fibronectin binding, or Curli production. Infect. Immun. 60: 4460-4467.
59. Rasko DA, et al. 2008. Targeting QseC signaling and virulence for antibiotic development. Science 321:1078-1080.
60. Ron EZ. 2006. Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr. Opin. Microbiol. 9:28-32.
61. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 5:449-456.
62. Sabri M, Houle S, Dozois CM. 2009. Roles of the extraintestinal pathogenic Escherichia coli ZnuACB and ZupT zinc transporters during urinary tract infection. Infect. Immun. 77:1155-1164.
63. Schwan WR, Lee JL, Lenard FA, Matthews BT, Beck MT. 2002. Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli. Infect. Immun. 70: 1391-1402.
64. Schwan WR, Shibata S, Aizawa S, Wolfe AJ. 2007. The two-component response regulator RcsB regulates type 1 piliation in Escherichia coli. J. Bacteriol. 189:7159-7163.
65. Simon R, Priefer U, Pühler A. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Nat. Biotechnol. 1:784-794.
66. Smith SN, Hagan EC, Lane MC, Mobley HL. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. mBio 1(5):e00262-10. doi:10.1128/mBio.00262-10.
67. Snyder JA, et al. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72:6373-6381.
68. Snyder JA, Lloyd AL, Lockatell CV, Johnson DE, Mobley HL. 2006. Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect. Immun. 74:1387-1393.
69. Sohanpal BK, El-Labany S, Lahooti M, Plumbridge JA, Blomfield IC. 2004. Integrated regulatory responses of fimB to N-acetylneuraminic (sialic) acid and GlcNAc in Escherichia coli K-12. Proc. Natl. Acad. Sci. U. S. A. 101:16322-16327.
70. Spira B, Silberstein N, Yagil E. 1995. Guanosine 3=,5=-bispyrophosphate (ppGpp) synthesis in cells of Escherichia coli starved for Pi. J. Bacteriol. 177:4053-4058.
71. Spira B, Yagil E. 1998. The relation between ppGpp and the PHO regulon in Escherichia coli. Mol. Gen. Genet. 257:469-477.
72. Stentebjerg-Olesen B, Chakraborty T, Klemm P. 2000. FimE-catalyzed off-to-on inversion of the type 1 fimbrial phase switch and insertion sequence recruitment in an Escherichia coli K-12 fimB strain. FEMS Microbiol. Lett. 182:319-325.
73. Stentebjerg-Olesen B, Chakraborty T, Klemm P. 1999. Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917. J. Bacteriol. 181:7470-7478.
74. Stephenson K, Hoch JA. 2004. Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms. Curr. Med. Chem. 11:765-773.
75. Struve C, Krogfelt KA. 1999. In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection. Microbiology 145:2683-2690.
76. Svitil AL, Cashel M, Zyskind JW. 1993. Guanosine tetraphosphate inhibits protein synthesis in vivo. A possible protective mechanism for starvation stress in Escherichia coli. J. Biol. Chem. 268:2307-2311.
77. Traxler MF, et al. 2011. Discretely calibrated regulatory loops controlled by ppGpp partition gene induction across the 'feast to famine' gradient in Escherichia coli. Mol. Microbiol. 79:830-845.
78. Virkola R, et al. 1988. Binding characteristics of Escherichia coli adhesins in human urinary bladder. Infect. Immun. 56:2615-2622.
79. Wanner BL. 1996. Phosphorus assimilation and control of the phosphate regulon, p 1357-1381. In Neidhardt FC, et al (ed), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed, vol 1. American Society for Microbiology, Washington, DC.
80. Welch RA, et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024.
81. West AH, Stock AM. 2001. Histidine kinases and response regulator proteins in two-component signaling systems. Trends Biochem. Sci. 26: 369-376.
82. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-19.
83. Wiltshire C, Matsushita M, Tsukada S, Gillespie DA, May GH. 2002. A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem. J. 367:577-585.
84. Woodall LD, Russell PW, Harris SL, Orndorff PE. 1993. Rapid, synchronous, and stable induction of type 1 piliation in Escherichia coli by using a chromosomal lacUV5 promoter. J. Bacteriol. 175:2770-2778.
85. Wright KJ, Seed PC, Hultgren SJ. 2007. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell. Microbiol. 9:2230-2241.
86. Wu Y, Outten FW. 2009. IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression. J. Bacteriol. 191:1248-1257.
87. Xiao H, et al. 1991. Residual guanosine 3=,5=-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J. Biol. Chem. 266:5980-5990.